Uptake of postplacental intrauterine device placement at cesarean deliveryAJOG Global Reports at a Glance

BACKGROUND: Several studies have investigated the effectiveness of intrauterine device placement at cesarean delivery as a contraceptive method. However, national-level use and outcomes of a postplacental intrauterine device at cesarean delivery are currently understudied in the United States. OBJEC...

Full description

Saved in:
Bibliographic Details
Published in:AJOG global reports 2023-02, Vol.3 (1), p.100157
Main Authors: Heather E. Sweeney, MD, Liat Bainvoll, BS, Rachel S. Mandelbaum, MD, Rauvynne N. Sangara, MD, Caroline J. Violette, MD, Maximilian Klar, MD, MPH, Kazuhide Matsushima, MD, Richard J. Paulson, MD, Sigita S. Cahoon, MD, MPH, Brian T. Nguyen, MD, Nicole M. Bender, MD, Joseph G. Ouzounian, MD, MBA, Koji Matsuo, MD, PhD
Format: Article
Language:English
Subjects:
cesarean delivery
characteristics
morbidity
postplacental intrauterine device
trends
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND: Several studies have investigated the effectiveness of intrauterine device placement at cesarean delivery as a contraceptive method. However, national-level use and outcomes of a postplacental intrauterine device at cesarean delivery are currently understudied in the United States. OBJECTIVE: This study aimed to examine the trends, characteristics, and outcomes of patients who received a postplacental intrauterine device at cesarean delivery. STUDY DESIGN: This retrospective cohort study used the National Inpatient Sample. The study cohort included patients who underwent cesarean delivery from October 2015 to December 2018. The exclusion criteria included hemorrhage, chorioamnionitis, uterine anomaly, hysterectomy, and permanent surgical sterilization. Eligible cases were grouped on the basis of the use of a postplacental intrauterine device at cesarean delivery. The primary outcome measures were temporal trends and characteristics associated with the use of a postplacental intrauterine device at cesarean delivery, assessed using the generalized estimating equation model in multivariable analysis. The secondary outcome measure was perioperative morbidity (leukocytosis, endometritis, myometritis, and sepsis). Propensity score matching was used to balance the baseline characteristics. RESULTS: Among 2,983,978 patients who met the inclusion criteria, 10,145 patients (0.3%) received a postplacental intrauterine device at cesarean delivery. The use of a postplacental intrauterine device increased from 0.1% in the fourth quarter of 2015 to 0.6% in the fourth quarter of 2018 (P
ISSN:2666-5778
2666-5778